FIELD: preparative and technical biochemistry. SUBSTANCE: invention relates to preparing the biologically active chemical compound - protein product used both in cellular biology and practical medicine and veterinary science. Invention relates to glycoprotein isolated from animal and human blood serum of the following formula of N-terminal fragment: R-Asn-Thr-Pro-Lys-Gly-Ile-Ala-Ala-Ala-Phe-Lys where R - a residue of oligosaccharide of the general formula: (Man)3-5-(GleNAc)2 where Man - a residue of mannose; GlcNAc - a residue of N-acetylglucoseamine. Serum glycoprotein shows the biological activity at superlow doses - at concentrations 10-14-10-19 M, its molecular mass is 12.5 kDa. EFFECT: glycoprotein indicated above, high biological activity of glycoprotein. 6 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW CLASS OF PHYSIOLOGICALLY ACTIVE GLYCOPROTEINS | 2000 |
|
RU2223781C2 |
| METHOD OF OBTAINING COLLAGENASE INHIBITOR WITH ANTI-TUMOUR ACTION FROM HEPATOPANCREAS OF RED KING CRAB | 2009 |
|
RU2412995C1 |
| PROTEIN CAUSEING CELL AUTOAGGLUTINATION PROPERTY OF PLAGUE MICROBES, AND METHOD FOR PRODUCING IT | 2011 |
|
RU2473558C1 |
| OPHTHALMOLOGICAL MEDICINAL AGENT AND METHOD FOR TREATMENT OF RETINA DISEASE, PATHOLOGICAL STATE AND INJURY | 2003 |
|
RU2232586C1 |
| METHOD OF PRODUCING ANTICOAGULATIVE COLLAGENASE INHIBITOR FROM KING CRAB HEPATOPANCREAS | 2009 |
|
RU2403284C1 |
| METHOD TO PRODUCE ESTROGEN-BINDING PROTEIN ASSOCIATED WITH MALIGNANT TUMORS | 2012 |
|
RU2489440C1 |
| METHOD FOR PRODUCTION OF COLLAGENASE INHIBITOR FROM HEPATOPANCREAS OF COMMERCIAL CRAB SPECIES | 2005 |
|
RU2292393C2 |
| METHOD OF PREPARING CHOLESTEROL-ESTERASE, TRIPSIN, DEOXYRIBONUCLEASE, AND RIBONUCLEASE FROM BOVINE PANCREAS | 2005 |
|
RU2311455C2 |
| PHARMACOLOGICAL SUBSTANCE OF MEMBRANOTROPIC HOMEOSTATIC TISSUE-SPECIFIC BIOREGULATORS ISOLATED FROM VARIOUS TISSUES AND BIOLOGICAL FLUIDS OF ANIMALS | 2021 |
|
RU2797514C1 |
| METHOD OF PRODUCING MACROGLOBULING | 0 |
|
SU961695A1 |
